adult intraventricular hemorrhage market size, adult intraventricular hemorrhage medical devices market, adult intraventricular hemorrhage market insights, adult intraventricular hemorrhage market share, intraventricular hemorrhage in adults market, adult intraventricular hemorrhage market
At what pace is the adult intraventricular hemorrhage market growing, and what is its estimated value?
The adult intraventricular hemorrhage market size has grown strongly in recent years. It will grow from $2.09 billion in 2024 to $2.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to advancements in neuroimaging techniques, an increase in hypertension and cardiovascular diseases, the growing elderly population, an increase in incidents of traumatic brain injuries, and medical technology innovations.
The adult intraventricular hemorrhage market size is expected to see strong growth in the next few years. It will grow to $2.82 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to innovations in minimally invasive surgical techniques, enhanced healthcare infrastructure, increased focus on stroke prevention and management, development of new pharmacological treatments, and growing awareness and education programs. Major trends in the forecast period include the rise of telemedicine and remote monitoring, the development of targeted therapies, the expansion of comprehensive stroke centers, enhanced rehabilitation services, and a trend toward personalized medicine.
Get Your Free Sample of The Global Adult Intraventricular Hemorrhage Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17051&type=smp
What are the top drivers to the rising demand in the adult intraventricular hemorrhage market?
The increasing incidence of strokes is expected to propel the growth of the adult intraventricular hemorrhage market going forward. A stroke is a medical emergency that occurs when blood flow to the brain is interrupted or reduced, leading to brain cell damage. The increasing incidence of strokes is primarily due to factors such as an aging population, rising rates of hypertension, diabetes, and obesity, and lifestyle-related risk factors such as smoking and physical inactivity. Strokes can cause adult intraventricular hemorrhage (IVH) by leading to bleeding within the brain’s ventricular system, often due to ruptured blood vessels. For instance, in November 2023, according to the Socialstyrelsen, a Sweden-based government agency, in 2022, approximately 26,800 stroke cases were reported, impacting around 25,100 individuals, which is about 300 fewer people compared to 2021. Therefore, the increasing incidence of strokes is driving the growth of the adult intraventricular hemorrhage market.
How is the adult intraventricular hemorrhage market segmented?
The adult intraventricular hemorrhage market covered in this report is segmented –
1) By Product Type: Surgical Devices, Drugs, Monitoring Devices
2) By Distribution Channel: Direct Sales, Distributors, Online Platforms, Other Distribution Channels
3) By Application: Intraventricular Hemorrhage, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Other Applications
4) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Other End-Users
Subsegments:
1) By Surgical Devices: Craniotomy Instruments, External Ventricular Drainage (EVD) Systems, Surgical Clips And Staples, Endoscopic Tools
2) By Drugs: Hemostatic Agents, Antihypertensive Drugs, Anticoagulants aAnd Antiplatelet Drugs, Sedatives And Analgesics
3) By Monitoring Devices: Intracranial Pressure (ICP) Monitors, Brain Oxygenation Monitors, Cerebral Blood Flow (CBF) Monitors, Neuroimaging Devices
Order your report now for swift delivery
Who are the top competitors in the adult intraventricular hemorrhage market?
Major companies operating in the adult intraventricular hemorrhage market are Johnson and Johnson, Abbott Laboratories, Medtronic Plc, Siemens Healthineers, Medline Industries, Philips Healthcare Inc., Stryker Corporation, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Alcon Inc., Zimmer Biomet Holdings Inc., Olympus Corporation, Smith and Nephew, Kaneka Corporation, Karl Storz SE and Co. KG, Carl Zeiss Meditec AG, Integra Lifesciences Holdings Corp, Elekta AB, Leica Microsystems GmbH, KLS Martin Group, Natus Medical Incorporated, Aesculap Inc., NeuroPace Inc., Sophysa USA Inc, Spiegelberg GmbH and Co. KG, Vivonics Inc.
What significant trends should we anticipate in the adult intraventricular hemorrhage market over the forecast period?
Major companies operating in the adult intraventricular hemorrhage market are focused on developing innovative products, such as neuroaccess devices, for neurovascular management of ischemic and hemorrhagic strokes. Neuroaccess devices are medical tools used to gain entry to the brain or spinal cord for diagnostic or therapeutic procedures. For instance, in June 2024, Penumbra Inc., a US-based medical device company, announced the CE Mark approval and European launch of its BMX81 and BMX96 neuroaccess devices for managing ischemic and hemorrhagic stroke. These devices are designed for the neurovascular management of ischemic and hemorrhagic strokes and are Penumbra’s most advanced neuroaccess offerings. Unlike traditional access catheters, the BMX81 and BMX96 are made using laser-cut stainless steel hypo tube technology, offering stability and trackability to allow physicians to easily navigate the brain’s complex anatomy.
Which regional trends are influencing the adult intraventricular hemorrhage market, and which area dominates the industry?
North America was the largest region in the adult intraventricular hemorrhage market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult intraventricular hemorrhage market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Adult Intraventricular Hemorrhage Market Report 2025 Offer?
The adult intraventricular hemorrhage market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Adult intraventricular hemorrhage (IVH) is a type of bleeding that occurs within the brain’s ventricular system, where cerebrospinal fluid is produced and circulates. It often results from trauma, stroke, or other conditions that cause blood vessels in the brain to rupture. IVH can lead to increased intracranial pressure, hydrocephalus, and neurological damage, requiring prompt medical intervention.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17051
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
